HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S J Forman Selected Research

Chimeric Antigen Receptors

1/2017Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.
8/2013Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S J Forman Research Topics

Disease

11Neoplasms (Cancer)
01/2017 - 02/2000
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
10/2011 - 02/2000
9Leukemia
01/2015 - 01/2000
7Lymphoma (Lymphomas)
01/2006 - 01/2000
7Graft vs Host Disease (Graft-Versus-Host Disease)
06/2004 - 01/2000
4Hodgkin Disease (Hodgkin's Disease)
01/2018 - 03/2000
4Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2015 - 05/2000
4Hematologic Neoplasms (Hematological Malignancy)
04/2013 - 02/2000
4Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2012 - 03/2000
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2008 - 02/2000
3Infections
12/2008 - 05/2001
2Breast Neoplasms (Breast Cancer)
12/2009 - 06/2001
2Multiple Myeloma
05/2006 - 02/2000
2HIV Infections (HIV Infection)
10/2003 - 08/2000
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2017
1Bites and Stings (Sting)
01/2017
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2012
1Cardiovascular Diseases (Cardiovascular Disease)
02/2012
1Myeloid Leukemia (Leukemia, Myelocytic)
10/2011
1Iron Overload
12/2008
1Vaccinia
08/2008
1Refractory Anemia with Excess of Blasts (RAEM)
11/2007
1Disease Progression
10/2003
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2003
1Stomatitis
06/2001
1Carcinoma (Carcinomatosis)
06/2001
1Aplastic Anemia (Anemia, Hypoplastic)
01/2001
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
09/2000
1AIDS-Related Lymphoma (Lymphoma, AIDS Related)
08/2000
1Second Primary Neoplasms (Neoplasms, Second)
06/2000

Drug/Important Bio-Agent (IBA)

5Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2004 - 01/2000
3Methotrexate (Mexate)FDA LinkGeneric
01/2001 - 01/2000
2Chimeric Antigen ReceptorsIBA
01/2017 - 08/2013
2Imatinib Mesylate (Gleevec)FDA Link
04/2008 - 06/2005
2Melphalan (Alkeran)FDA LinkGeneric
11/2007 - 06/2004
2fludarabineIBA
11/2007 - 06/2004
2Mycophenolic Acid (Cellcept)FDA LinkGeneric
06/2004 - 10/2003
2Interleukin-2 (IL2)IBA
01/2003 - 02/2000
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2001 - 01/2001
2Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
05/2001 - 01/2001
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2000 - 11/2000
2Prednisone (Sone)FDA LinkGeneric
01/2000 - 01/2000
1Brentuximab VedotinIBA
01/2018
1Bispecific AntibodiesIBA
01/2017
1Surface Antigens (Surface Antigen)IBA
01/2017
1blinatumomabIBA
01/2017
1Messenger RNA (mRNA)IBA
01/2015
1Peptides (Polypeptides)IBA
08/2013
1Pharmaceutical PreparationsIBA
03/2012
1Farnesyltranstransferase (Farnesyltransferase)IBA
10/2011
1tipifarnib (R115777)IBA
10/2011
1Ferritins (Ferritin)IBA
12/2008
1Immunodominant EpitopesIBA
08/2008
1VaccinesIBA
08/2008
1Tyrosine Kinase InhibitorsIBA
04/2008
1Thalidomide (Thalomid)FDA Link
05/2006
1Phosphotransferases (Kinase)IBA
06/2005
1CytokinesIBA
01/2003
1Paclitaxel (Taxol)FDA LinkGeneric
06/2001
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2001
1SteroidsIBA
05/2001
1Filgrastim (Neupogen)FDA Link
01/2001
1Dihydrotachysterol (AT 10)IBA
01/2001
1nuclear pore complex protein 98IBA
11/2000
1lens epithelium-derived growth factorIBA
11/2000
1Etoposide (VP 16)FDA LinkGeneric
09/2000
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2000
1Daunorubicin (Cerubidine)FDA LinkGeneric
07/2000
1Biological ProductsIBA
07/2000
1Cytarabine (Cytosar-U)FDA LinkGeneric
07/2000
1InterleukinsIBA
02/2000

Therapy/Procedure

16Therapeutics
01/2018 - 01/2000
10Stem Cell Transplantation
01/2018 - 03/2000
9Transplantation
11/2007 - 02/2000
7Cell Transplantation
01/2018 - 02/2000
6Drug Therapy (Chemotherapy)
01/2015 - 01/2000
5Hematopoietic Stem Cell Transplantation
12/2009 - 05/2000
3Immunotherapy
01/2017 - 02/2000
3Autologous Transplantation
10/2003 - 02/2000
1Adjuvant Chemotherapy
12/2009
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2001
1Highly Active Antiretroviral Therapy (HAART)
08/2000
1Radiotherapy
06/2000
1Chemoradiotherapy
03/2000
1Homologous Transplantation
02/2000